EcoDrugPlus

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSBMUG00000011030
Gene Symbol: TRHR
3 Cross references
269 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSBMUG00000009019
Gene Symbol: TLR2
3 Cross references
249 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSBMUG00000009529
Gene Symbol: TLR4
3 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSBMUG00000014743
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSBMUG00000014752
Gene Symbol: TLR8
3 Cross references
199 Possible Orthologues:

Toll Like Receptor 9

Ensembl ID : ENSBMUG00000007976
Gene Symbol: TLR9
3 Cross references
82 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSBMUG00000007889
Gene Symbol: TAAR1
3 Cross references
600 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSBMUG00000006453
Gene Symbol: TGFBR1
3 Cross references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSBMUG00000018904
Gene Symbol: TRPA1
3 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSBMUG00000025467
Gene Symbol: TRPM8
3 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSBMUG00000011977
Gene Symbol: TRPV1
3 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSBMUG00000003963
Gene Symbol: TSPO
3 Cross references
122 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).